Rezolute Inc (RZLT) Stock Analysis

Rezolute Inc (RZLT) is a publicly traded company in the HEALTHCARE sector. It trades at $3.61, carries a market capitalization of $347.62M. This page summarizes the public market data, fundamentals, and frequently asked questions for RZLT, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $3.61
• Market Cap: $347.62M
• EPS: $-0.81
• 52-Week High: $11.46
• 52-Week Low: $1.07

Market Sentiment

Rezolute Inc currently has a Bullish sentiment score of 0.43.

About Rezolute Inc

Rezolute, Inc. is a clinical-stage biopharmaceutical company headquartered in Redwood City, California, dedicated to developing innovative therapies for rare and metabolic diseases. The company boasts a promising pipeline targeting significant unmet medical needs, underpinned by its commitment to scientific advancement and clinical excellence. Through strategic collaborations and a focus on improving patient outcomes, Rezolute is uniquely positioned to make a substantial impact in the biophar...

GNG Research Analysis

GNG Research scores Rezolute Inc (RZLT) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for RZLT.

Frequently Asked Questions

Does RZLT pay dividends?

Rezolute Inc (RZLT) does not currently pay a regular dividend.

What is RZLT's market cap?

Rezolute Inc (RZLT) has a market capitalization of $347.62M with a current stock price of $3.61.